Reimbursement Ready

Billable ICD-10-CM Codes - Page 349

A comprehensive listing of specific diagnosis codes that indicate the highest level of clinical detail for reimbursement purposes.

Encounter for other screening for genetic and chromosomal anomalies
Status: Billable
Z13.79
Encounter for screening for upper gastrointestinal disorder
Status: Billable
Z13.810
Encounter for screening for lower gastrointestinal disorder
Status: Billable
Z13.811
Encounter for screening for other digestive system disorders
Status: Billable
Z13.818
Encounter for screening for osteoporosis
Status: Billable
Z13.820
Encounter for screening for other musculoskeletal disorder
Status: Billable
Z13.828
Encounter for screening for respiratory disorder NEC
Status: Billable
Z13.83
Encounter for screening for dental disorders
Status: Billable
Z13.84
Encounter for screening for traumatic brain injury
Status: Billable
Z13.850
Encounter for screening for other nervous system disorders
Status: Billable
Z13.858
Encounter for screening for disorder due to exposure to contaminants
Status: Billable
Z13.88
Encounter for screening for other disorder
Status: Billable
Z13.89
Encounter for screening, unspecified
Status: Billable
Z13.9
Asymptomatic hemophilia A carrier
Status: Billable
Z14.01
Symptomatic hemophilia A carrier
Status: Billable
Z14.02
Cystic fibrosis carrier
Status: Billable
Z14.1
Genetic carrier of other disease
Status: Billable
Z14.8
Genetic susceptibility to malignant neoplasm of breast
Status: Billable
Z15.01
Genetic susceptibility to malignant neoplasm of ovary
Status: Billable
Z15.02
Genetic susceptibility to malignant neoplasm of prostate
Status: Billable
Z15.03
Genetic susceptibility to malignant neoplasm of endometrium
Status: Billable
Z15.04
Genetic susceptibility to malignant neoplasm of fallopian tube(s)
Status: Billable
Z15.05
Genetic susceptibility to colorectal cancer
Status: Billable
Z15.060
Genetic susceptibility to other malignant neoplasm of digestive system
Status: Billable
Z15.068
Genetic susceptibility to malignant neoplasm of urinary tract
Status: Billable
Z15.07
Genetic susceptibility to other malignant neoplasm
Status: Billable
Z15.09
Genetic susceptibility to epilepsy and neurodevelopmental disorders
Status: Billable
Z15.1
Genetic susceptibility to obesity
Status: Billable
Z15.2
Genetic susceptibility to kidney disease
Status: Billable
Z15.3
Genetic susceptibility to multiple endocrine neoplasia [MEN]
Status: Billable
Z15.81
Genetic susceptibility to other disease
Status: Billable
Z15.89
Resistance to unspecified beta lactam antibiotics
Status: Billable
Z16.10
Resistance to penicillins
Status: Billable
Z16.11
Extended spectrum beta lactamase (ESBL) resistance
Status: Billable
Z16.12
Resistance to carbapenem
Status: Billable
Z16.13
Resistance to other specified beta lactam antibiotics
Status: Billable
Z16.19
Resistance to unspecified antibiotic
Status: Billable
Z16.20
Resistance to vancomycin
Status: Billable
Z16.21
Resistance to vancomycin related antibiotics
Status: Billable
Z16.22
Resistance to quinolones and fluoroquinolones
Status: Billable
Z16.23
Resistance to multiple antibiotics
Status: Billable
Z16.24
Resistance to other single specified antibiotic
Status: Billable
Z16.29
Resistance to unspecified antimicrobial drugs
Status: Billable
Z16.30
Resistance to antiparasitic drug(s)
Status: Billable
Z16.31
Resistance to antifungal drug(s)
Status: Billable
Z16.32
Resistance to antiviral drug(s)
Status: Billable
Z16.33
Resistance to single antimycobacterial drug
Status: Billable
Z16.341
Resistance to multiple antimycobacterial drugs
Status: Billable
Z16.342
Resistance to multiple antimicrobial drugs
Status: Billable
Z16.35
Resistance to other specified antimicrobial drug
Status: Billable
Z16.39
Estrogen receptor positive status [ER+]
Status: Billable
Z17.0
Estrogen receptor negative status [ER-]
Status: Billable
Z17.1
Progesterone receptor positive status
Status: Billable
Z17.21
Progesterone receptor negative status
Status: Billable
Z17.22
Human epidermal growth factor receptor 2 positive status
Status: Billable
Z17.31
Human epidermal growth factor receptor 2 negative status
Status: Billable
Z17.32
Hormone receptor positive with human epidermal growth factor receptor 2 positive status
Status: Billable
Z17.410
Hormone receptor positive with human epidermal growth factor receptor 2 negative status
Status: Billable
Z17.411
Hormone receptor negative with human epidermal growth factor receptor 2 positive status
Status: Billable
Z17.420
Hormone receptor negative with human epidermal growth factor receptor 2 negative status
Status: Billable
Z17.421
Retained depleted uranium fragments
Status: Billable
Z18.01
Other retained radioactive fragments
Status: Billable
Z18.09
Retained metal fragments, unspecified
Status: Billable
Z18.10
Retained magnetic metal fragments
Status: Billable
Z18.11
Retained nonmagnetic metal fragments
Status: Billable
Z18.12
Retained plastic fragments
Status: Billable
Z18.2
Retained animal quills or spines
Status: Billable
Z18.31
Retained tooth
Status: Billable
Z18.32
Retained wood fragments
Status: Billable
Z18.33
Other retained organic fragments
Status: Billable
Z18.39
Retained glass fragments
Status: Billable
Z18.81
Retained stone or crystalline fragments
Status: Billable
Z18.83
Other specified retained foreign body fragments
Status: Billable
Z18.89
Retained foreign body fragments, unspecified material
Status: Billable
Z18.9
Hormone sensitive malignancy status
Status: Billable
Z19.1
Hormone resistant malignancy status
Status: Billable
Z19.2
Contact with and (suspected) exposure to intestinal infectious diseases due to Escherichia coli (E. coli)
Status: Billable
Z20.01
Contact with and (suspected) exposure to other intestinal infectious diseases
Status: Billable
Z20.09
Contact with and (suspected) exposure to tuberculosis
Status: Billable
Z20.1
Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission
Status: Billable
Z20.2
Contact with and (suspected) exposure to rabies
Status: Billable
Z20.3
Contact with and (suspected) exposure to rubella
Status: Billable
Z20.4
Contact with and (suspected) exposure to viral hepatitis
Status: Billable
Z20.5
Contact with and (suspected) exposure to human immunodeficiency virus [HIV]
Status: Billable
Z20.6
Contact with and (suspected) exposure to pediculosis, acariasis and other infestations
Status: Billable
Z20.7
Contact with and (suspected) exposure to anthrax
Status: Billable
Z20.810
Contact with and (suspected) exposure to meningococcus
Status: Billable
Z20.811
Contact with and (suspected) exposure to other bacterial communicable diseases
Status: Billable
Z20.818
Contact with and (suspected) exposure to varicella
Status: Billable
Z20.820
Contact with and (suspected) exposure to Zika virus
Status: Billable
Z20.821
Contact with and (suspected) exposure to COVID-19
Status: Billable
Z20.822
Contact with and (suspected) exposure to other viral communicable diseases
Status: Billable
Z20.828
Contact with and (suspected) exposure to other communicable diseases
Status: Billable
Z20.89
Contact with and (suspected) exposure to unspecified communicable disease
Status: Billable
Z20.9
Carrier of typhoid
Status: Billable
Z22.0
Carrier of other intestinal infectious diseases
Status: Billable
Z22.1
Carrier of diphtheria
Status: Billable
Z22.2
Carrier of bacterial disease due to meningococci
Status: Billable
Z22.31
Carrier or suspected carrier of Methicillin susceptible Staphylococcus aureus
Status: Billable
Z22.321
Carrier or suspected carrier of Methicillin resistant Staphylococcus aureus
Status: Billable
Z22.322